| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2026 ( Subtotal = $72,972,635 ) (Continued on the next page) |
| | 2026 | 2026 | SEATTLE CHILDREN'S HOSPITAL | 4800 SAND POINT WAY NE | SEATTLE | WA | 98105-3901 | KING | USA | R01HL166317 | Unraveling a parabrachial circuit for the state-dependent control of rapid breathing | 001 | 4 | NIH | 3/25/2026 | $26,575 |
| | 2026 | 2026 | SEATTLE CHILDREN'S HOSPITAL | 4800 SAND POINT WAY NE | SEATTLE | WA | 98105-3901 | KING | USA | R01HL166317 | Unraveling a parabrachial circuit for the state-dependent control of rapid breathing | 000 | 4 | NIH | 3/5/2026 | $841,553 |
| | 2026 | 2026 | SEATTLE CHILDREN'S HOSPITAL | 4800 SAND POINT WAY NE | SEATTLE | WA | 98105-3901 | KING | USA | R25NS141155 | Summer Undergraduate Program to Advance Research and Quality in Pain and Neurological Health | 000 | 2 | NIH | 2/24/2026 | $129,113 |
| | 2026 | 2026 | SEATTLE CHILDREN'S HOSPITAL | 4800 SAND POINT WAY NE | SEATTLE | WA | 98105-3901 | KING | USA | K01MD019730 | Extreme weather and mental health content on social media: Promoting racial and ethnic minority youth psychosocial resilience | 000 | 4 | NIH | 2/15/2026 | $127,370 |
| | 2026 | 2026 | SEATTLE CHILDREN'S HOSPITAL | 4800 SAND POINT WAY NE | SEATTLE | WA | 98105-3901 | KING | USA | R00NS112575 | Dissecting the Action Learning Process with Dopaminergic Reinforcement | 000 | 5 | NIH | 3/5/2026 | $248,995 |
| | 2026 | 2026 | SEATTLE CHILDREN'S HOSPITAL | 4800 SAND POINT WAY NE | SEATTLE | WA | 98105-3901 | KING | USA | R01AI188789 | Species-transcending prevention of mosquito vector infection | 000 | 2 | NIH | 12/31/2025 | $808,475 |
| | 2026 | 2026 | SEATTLE CHILDREN'S HOSPITAL | 4800 SAND POINT WAY NE | SEATTLE | WA | 98105-3901 | KING | USA | R01AI188789 | Species-transcending prevention of mosquito vector infection | 001 | 2 | NIH | 7/2/2026 | -$427,108 |
| | 2026 | 2026 | SEATTLE CHILDREN'S HOSPITAL | 4800 SAND POINT WAY NE | SEATTLE | WA | 98105-3901 | KING | USA | R01NS143924 | Modeling mTOR network dynamics to achieve optimal drug rescue of congenital mTORopathies | 000 | 2 | NIH | 4/27/2026 | $704,697 |
| | 2026 | 2026 | SEATTLE CHILDREN'S HOSPITAL | 4800 SAND POINT WAY NE | SEATTLE | WA | 98105-3901 | KING | USA | R01HD116748 | Understanding Longitudinal Relationships between Sleep and Menstrual Pain in Adolescents | 000 | 2 | NIH | 5/22/2026 | $762,355 |
| | 2026 | 2026 | SEATTLE CHILDREN'S HOSPITAL | 4800 SAND POINT WAY NE | SEATTLE | WA | 98105-3901 | KING | USA | U01DA060443 | Deep Analysis of Transcriptome to Understand the Genetics of Substance Use Disorders in Rats | 000 | 2 | NIH | 3/27/2026 | $882,279 |
| | 2026 | 2026 | SEATTLE CHILDREN'S HOSPITAL | 4800 SAND POINT WAY NE | SEATTLE | WA | 98105-3901 | KING | USA | R01HD106628 | Supraphysiologic Shear Stresses Associated with Cardiopulmonary Bypass are Sufficient to Activate RIKP3 Signaling | 000 | 5 | NIH | 3/3/2026 | $725,965 |
| | 2026 | 2026 | SEATTLE CHILDREN'S HOSPITAL | 4800 SAND POINT WAY NE | SEATTLE | WA | 98105-3901 | KING | USA | R01AG081840 | Pericyte control of capillary perfusion in the Alzheimer's disease brain | 001 | 4 | NIH | 2/25/2026 | $84,440 |
| | 2026 | 2026 | SEATTLE CHILDREN'S HOSPITAL | 4800 SAND POINT WAY NE | SEATTLE | WA | 98105-3901 | KING | USA | R01AG081840 | Pericyte control of capillary perfusion in the Alzheimer's disease brain | 000 | 4 | NIH | 2/2/2026 | $759,966 |
| | 2026 | 2026 | SEATTLE CHILDREN'S HOSPITAL | 4800 SAND POINT WAY NE | SEATTLE | WA | 98105-3901 | KING | USA | R01AI151167 | Manipulating alpha(v) integrins on B cells to promote lung-resident B cell responses | 000 | 5 | NIH | 3/27/2026 | $767,781 |
| | 2026 | 2026 | SEATTLE CHILDREN'S HOSPITAL | 4800 SAND POINT WAY NE | SEATTLE | WA | 98105-3901 | KING | USA | RF1AG062738 | Pericyte Structural Plasticity and Cerebrovascular Health in a Model of Type-1 Cerebral Amyloid Angiopathy | 000 | 6 | NIH | 6/19/2026 | $3,642,948 |
| | 2026 | 2026 | SEATTLE CHILDREN'S HOSPITAL | 4800 SAND POINT WAY NE | SEATTLE | WA | 98105-3901 | KING | USA | R01CA258866 | IL-15 and -21 armored GPC3-specific CAR T cells for children with solid tumors | 001 | 5 | NIH | 2/19/2026 | $615,969 |
| | 2026 | 2026 | SEATTLE CHILDREN'S HOSPITAL | 4800 SAND POINT WAY NE | SEATTLE | WA | 98105-3901 | KING | USA | R01AI163160 | Dysregulated asthmatic epithelial interferon responses to viruses drive exacerbation, T2 inflammation, and airway remodeling | 000 | 5 | NIH | 1/22/2026 | $850,461 |
| | 2026 | 2026 | SEATTLE CHILDREN'S HOSPITAL | 4800 SAND POINT WAY NE | SEATTLE | WA | 98105-3901 | KING | USA | K08DK138302 | Epigenetic regulation of kidney regeneration | 000 | 3 | NIH | 5/28/2026 | $154,980 |
| | 2026 | 2026 | SEATTLE CHILDREN'S HOSPITAL | 4800 SAND POINT WAY NE | SEATTLE | WA | 98105-3901 | KING | USA | U01DK084575 | Continuation of the Childhood Liver Disease Research Network - Seattle Clinical Center | 001 | 18 | NIH | 6/12/2026 | $299,390 |
| | 2026 | 2026 | SEATTLE CHILDREN'S HOSPITAL | 4800 SAND POINT WAY NE | SEATTLE | WA | 98105-3901 | KING | USA | R01HL163103 | Hexosamine biosynthesis pathway metabolism during cardiac hypertrophy | 001 | 4 | NIH | 4/24/2026 | $23,368 |
| | 2026 | 2026 | SEATTLE CHILDREN'S HOSPITAL | 4800 SAND POINT WAY NE | SEATTLE | WA | 98105-3901 | KING | USA | R01HL163103 | Hexosamine biosynthesis pathway metabolism during cardiac hypertrophy | 000 | 4 | NIH | 2/27/2026 | $740,074 |
| | 2026 | 2026 | SEATTLE CHILDREN'S HOSPITAL | 4800 SAND POINT WAY NE | SEATTLE | WA | 98105-3901 | KING | USA | R01AI158536 | Uncovering the parasite and host determinants of Plasmodium vivax hypnozoite formation and development using single cell sequencing and human liver-chimeric mice | 001 | 5 | NIH | 4/2/2026 | $87,480 |
| | 2026 | 2026 | SEATTLE CHILDREN'S HOSPITAL | 4800 SAND POINT WAY NE | SEATTLE | WA | 98105-3901 | KING | USA | R01AI158536 | Uncovering the parasite and host determinants of Plasmodium vivax hypnozoite formation and development using single cell sequencing and human liver-chimeric mice | 000 | 5 | NIH | 3/20/2026 | $623,601 |
| | 2026 | 2026 | SEATTLE CHILDREN'S HOSPITAL | 4800 SAND POINT WAY NE | SEATTLE | WA | 98105-3901 | KING | USA | K08AI166072 | Dissecting the molecular regulation of T cell localization and function within the Mycobacterium tuberculosis granuloma | 000 | 5 | NIH | 1/28/2026 | $183,968 |
| | 2026 | 2026 | SEATTLE CHILDREN'S HOSPITAL | 4800 SAND POINT WAY NE | SEATTLE | WA | 98105-3901 | KING | USA | UM1DA058220 | 'Mosaicism in Human Tissues, from Telomere to Telomere to RFA-22-013: "Somatic Mosaicism across Human Tissues Program: Genome Characterization Centers." | 002 | 4 | NIH | 5/14/2026 | $6,749,998 |
| | 2026 | 2026 | SEATTLE CHILDREN'S HOSPITAL | 4800 SAND POINT WAY NE | SEATTLE | WA | 98105-3901 | KING | USA | R01AI181218 | Immunotherapeutic approach for the prevention of secondary infection with drug-resistant TB | 001 | 3 | NIH | 5/22/2026 | $968,051 |
| | 2026 | 2026 | SEATTLE CHILDREN'S HOSPITAL | 4800 SAND POINT WAY NE | SEATTLE | WA | 98105-3901 | KING | USA | R01DE032663 | Influence of viral and immune interventions on early events following oral SIV infection | 001 | 4 | NIH | 4/16/2026 | $79,837 |
| | 2026 | 2026 | SEATTLE CHILDREN'S HOSPITAL | 4800 SAND POINT WAY NE | SEATTLE | WA | 98105-3901 | KING | USA | R01DE032663 | Influence of viral and immune interventions on early events following oral SIV infection | 000 | 4 | NIH | 12/12/2025 | $718,535 |
| | 2026 | 2026 | SEATTLE CHILDREN'S HOSPITAL | 4800 SAND POINT WAY NE | SEATTLE | WA | 98105-3901 | KING | USA | U54AI170855 | Behavior of HIV in Viral Environments (B-HIVE) | 000 | 5 | NIH | 5/28/2026 | $5,819,586 |
| | 2026 | 2026 | SEATTLE CHILDREN'S HOSPITAL | 4800 SAND POINT WAY NE | SEATTLE | WA | 98105-3901 | KING | USA | R01ES033785 | Assessing how Prenatal Phthalate Exposure Disrupts Placental Transcriptional Regulation and Contributes to Changes in Gestational Length | 000 | 4 | NIH | 12/9/2025 | $678,164 |
| | 2026 | 2026 | SEATTLE CHILDREN'S HOSPITAL | 4800 SAND POINT WAY NE | SEATTLE | WA | 98105-3901 | KING | USA | R50CA275857 | Pediatric brain tumors: Improving survival through integration of clinical molecular diagnostics and biologically targeted therapies into clinical trials | 000 | 4 | NIH | 4/1/2026 | $175,338 |
| | 2026 | 2026 | SEATTLE CHILDREN'S HOSPITAL | 4800 SAND POINT WAY NE | SEATTLE | WA | 98105-3901 | KING | USA | K23HD107232 | A Novel Photo-Narrative Communication Intervention Among Parents of Children with Severe Neurological Impairment in the ICU | 000 | 5 | NIH | 6/18/2026 | $157,837 |
| | 2026 | 2026 | SEATTLE CHILDREN'S HOSPITAL | 4800 SAND POINT WAY NE | SEATTLE | WA | 98105-3901 | KING | USA | R01HD114797 | Evaluating Huddles as a Novel Approach to Improving Concussion Safety | 000 | 2 | NIH | 4/24/2026 | $742,561 |
| | 2026 | 2026 | SEATTLE CHILDREN'S HOSPITAL | 4800 SAND POINT WAY NE | SEATTLE | WA | 98105-3901 | KING | USA | R01AI170777 | Impairment of anti-Plasmodium T cell memory by type I Interferon Signaling | 000 | 4 | NIH | 5/19/2026 | $735,776 |
| | 2026 | 2026 | SEATTLE CHILDREN'S HOSPITAL | 4800 SAND POINT WAY NE | SEATTLE | WA | 98105-3901 | KING | USA | U01AI165455 | Collective Responses to Malaria Vaccination | 000 | 5 | NIH | 1/20/2026 | $700,000 |
| | 2026 | 2026 | SEATTLE CHILDREN'S HOSPITAL | 4800 SAND POINT WAY NE | SEATTLE | WA | 98105-3901 | KING | USA | R01HD109089 | Bifidobacterium infantis supplementation in early life to improve immunity in infants exposed to HIV: a randomized, placebo-controlled, double-blind trial | 001 | 5 | NIH | 5/25/2026 | $84,542 |
| | 2026 | 2026 | SEATTLE CHILDREN'S HOSPITAL | 4800 SAND POINT WAY NE | SEATTLE | WA | 98105-3901 | KING | USA | R01HD109089 | Bifidobacterium infantis supplementation in early life to improve immunity in infants exposed to HIV: a randomized, placebo-controlled, double-blind trial | 000 | 5 | NIH | 5/12/2026 | $686,430 |
| | 2026 | 2026 | SEATTLE CHILDREN'S HOSPITAL | 4800 SAND POINT WAY NE | SEATTLE | WA | 98105-3901 | KING | USA | R01DA056370 | Regulation of Opioid Sensitivity and Tolerance by Ubiquitin Ligase Signaling | 000 | 5 | NIH | 4/21/2026 | $605,352 |
| | 2026 | 2026 | SEATTLE CHILDREN'S HOSPITAL | 4800 SAND POINT WAY NE | SEATTLE | WA | 98105-3901 | KING | USA | R01DK131134 | Kids CoLab - Supporting collaborative decision making with youth impacted by chronic kidney disease | 000 | 5 | NIH | 7/1/2026 | $592,843 |
| | 2026 | 2026 | SEATTLE CHILDREN'S HOSPITAL | 4800 SAND POINT WAY NE | SEATTLE | WA | 98105-3901 | KING | USA | R01HD107794 | Randomized controlled trial of an internet-based prevention intervention for young children at-risk for functional abdominal pain | 000 | 5 | NIH | 4/1/2026 | $608,235 |
| | 2026 | 2026 | SEATTLE CHILDREN'S HOSPITAL | 4800 SAND POINT WAY NE | SEATTLE | WA | 98105-3901 | KING | USA | R01NS122902 | A Bioengineering Approach to Develop a Laminar 3D Cerebellar Neuronal Circuit for Modeling Human Cerebellum | 000 | 5 | NIH | 4/28/2026 | $688,366 |
| | 2026 | 2026 | SEATTLE CHILDREN'S HOSPITAL | 4800 SAND POINT WAY NE | SEATTLE | WA | 98105-3901 | KING | USA | R01AG077731 | Brain Drain: In Vivo Optical Interrogation of Venular Function in Gray and White Matter | 000 | 3 | NIH | 6/23/2026 | $777,730 |
| | 2026 | 2026 | SEATTLE CHILDREN'S HOSPITAL | 4800 SAND POINT WAY NE | SEATTLE | WA | 98105-3901 | KING | USA | R01AI192661 | Molecular and Functional Dissection of a Divergent mRNA Export Pathway | 000 | 1 | NIH | 5/7/2026 | $696,562 |
| | 2026 | 2026 | SEATTLE CHILDREN'S HOSPITAL | 4800 SAND POINT WAY NE | SEATTLE | WA | 98105-3901 | KING | USA | R01DA061865 | Elucidating locus coeruleus homeostatic mechanisms in opioid-induced sleep disturbances | 000 | 1 | NIH | 5/7/2026 | $574,954 |
| | 2026 | 2026 | SEATTLE CHILDREN'S HOSPITAL | 4800 SAND POINT WAY NE | SEATTLE | WA | 98105-3901 | KING | USA | R01AI200290 | The role of ferroptosis in regulating host control of M. tuberculosis infection | 000 | 1 | NIH | 7/6/2026 | $859,765 |
| | 2026 | 2026 | SEATTLE CHILDREN'S HOSPITAL | 4800 SAND POINT WAY NE | SEATTLE | WA | 98105-3901 | KING | USA | R01HD116794 | Randomized trial of a shared decision-making intervention for families about firearm storage | 000 | 2 | NIH | 6/19/2026 | $753,820 |
| | 2026 | 2026 | SEATTLE CHILDREN'S HOSPITAL | 4800 SAND POINT WAY NE | SEATTLE | WA | 98105-3901 | KING | USA | R01GM163160 | AI-designed Nanobodies for Detection and Manipulation Applications Inside Living Cells | 000 | 1 | NIH | 4/7/2026 | $2,096,292 |
| | 2026 | 2026 | SEATTLE CHILDREN'S HOSPITAL | 4800 SAND POINT WAY NE | SEATTLE | WA | 98105-3901 | KING | USA | R01CA300296 | Menin and Ewing Sarcoma Metastasis | 000 | 1 | NIH | 3/30/2026 | $636,097 |
| | 2026 | 2026 | SEATTLE CHILDREN'S HOSPITAL | 4800 SAND POINT WAY NE | SEATTLE | WA | 98105-3901 | KING | USA | R01AI189738 | Impact of vaccination and preterm delivery on maternal RSV-specific peripheral and mucosal immunity | 000 | 1 | NIH | 2/20/2026 | $862,347 |
|
